To facilitate generic drug product development, availability and to assist the generic pharmaceutical industry with identifying the most approved methodology for developing drugs and generating evidence needed to support ANDA approval, FDA regularly publishes product-specific guidances. Diary of Nonexclusive Drugs is the significant worldwide business diary composed by and for experts working in the conventional medications part. It incorporates master examination, briefings and legitimate reports on all parts of business advancement, administrative issues, assembling and advertising influencing the conventional pharmaceutical industry. Every quarterly issue distributes papers which are of direct significance to experts and that satisfy the most elevated scholarly guidelines.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 